BMJ19h
N18 in median somatosensory evoked potentials: a new indicator of medullary function useful for the diagnosis of brain death
Dr Masahiro Sonoo, Department of Neurology, Teikyo University School of Medicine, Kaga 2–11–1, Itabashi-ku, Tokyo 173, Japan. Telephone 0081 3 3964 1211 ext 1911; fax 0081 3 3964 6397; email sonoom{at ...
BMJ17h
Prognostication and contemporary management of clinically isolated syndrome
Clinically isolated syndrome (CIS) patients present with a single attack of inflammatory demyelination of the central nervous system. Recent advances in multiple sclerosis (MS) diagnostic criteria ...
BMJ1d
The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition
Background: Mild cognitive impairment (MCI) has been considered a transitional state between normal aging and dementia, characterised by memory impairment but normal general cognitive functioning.
BMJ2d
Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson’s disease
Background Global hippocampal atrophy is a hallmark of Alzheimer’s dementia and has been similarly reported in Parkinson’s disease dementia (PDD). However, there is limited literature on the ...
BMJ10d
Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study
Objective To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis (ALS). Methods 373 patients with ALS (El Escorial definite ...
BMJ3d
Deficient saccadic inhibition in Asperger’s disorder and the social-emotional processing disorder
1 Department of Psychiatry and the Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA 2 Department of Psychiatry, ...
BMJ11d
Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s disease
Loss of nigrostriatal dopaminergic projection neurons is a key pathology in Parkinson’s disease, leading to abnormal function of basal ganglia motor circuits and the accompanying characteristic motor ...
BMJ2d
Assessment of the severity of head injury.
Ranking of head injuries by severity is an essential part of clinical management, of prognosis, of treatment trials, and of legal assessment for compensation. Various methods of assessing severity are ...
BMJ5d
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
Background Early fast-acting treatment (EFT) is the aggressive use of fast-acting therapies such as plasmapheresis, intravenous immunoglobulin and/or intravenous high-dose methylprednisolone (IVMP) ...
BMJ8d
Psychiatric illness and subsequent traumatic brain injury: a case control study
1 Departments of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA 2 Departments of Rehabilitation Medicine and Pediatrics, University of Washington, Seattle, ...
BMJ9d
Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study
Department of Neurology, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland Correspondence to Dr Tuula Pirttilä, Department of Neurology, Bldg 5, Kuopio University Hospital POB ...
BMJ4d
Vasculitic polyradiculopathy in systemic lupus erythematosus
Dr G Midroni, Neurophysiology laboratory, St. Michael’s Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8. Telephone 00416 864 5193; fax 00416 864 6095. A 22 year old woman with recently ...